Ovarian cancer is the leading cause of gynecological cancer death in the USA. 1 Despite significant improvements in surgical treatment and chemotherapy, the overall 5-year survival rate remains poor.
Such an unsatisfactory survival rate is mainly due to low chance of early detection resulting in more than 60% of all patients being classified as stage III and IV at the time of diagnosis. 1 Therefore, new predictive and prognostic factors for ovarian cancer are in need to improve early detection rate and the efficacy of clinical management.
High-affinity interleukin-4 receptor (IL-4R) is expressed on a variety of nonhematopoietic tumor cells such as melanoma, ovarian, breast, and renal carcinoma cells. 2 
IL-4R
is a heterodimeric comprising the IL-4R and c chains. 3 In fact, signaling through the receptors of IL-4 has also some direct biological effects on these nonhematopoietic tumor cells, such as the production of IL-6. 4, 5 Recently, it was reported that there exist polymorphic site on the IL-4R gene which was associated with an increased risk of atopy 6, 7 and renal cell carcinoma (RCC). 8 tributed in patients with atopy or RCC by their genetic effects of predisposing the host immune system to be more susceptible for the diseases. [6] [7] [8] To clarify the significance of the IL-4R gene polymorphism in epithelial ovarian cancer (EOC) patients, we have examined how Ile50Val polymorphism influenced the incidence and prognosis in a series of 98 sporadic EOCs in Korean women. Hereby we report the association between the polymorphism of IL-4R Ile50Val and the risk and the survival for EOC for the first time.
The blood samples of 98 primary epithelial ovarian cancer patients who underwent surgery and/or chemotherapy at Seoul National University Hospital from 1999 to 2002 were collected. Final diagnoses were made on the basis of pathology reports of the specimens obtained by surgery. As a control, blood samples of 321 subjects who admitted at the same hospital with benign diseases were also obtained.
All of the subjects in the control group took exploratory laparotomy or pelviscopic surgery including the procedure of ovarian evaluation with inspection and/or palpation in order to confirm the lack of ovarian neoplasia. The study protocol was approved by an Institutional Review Board, and signed consents were obtained from all subjects after they had been advised of the study nature. Allele frequencies and genotype distributions in the cancer and control groups are summarized in (Table 2) . Interestingly, however, the survival analysis showed significant difference among genotypes. In this hospital-based case-control study, we found a significantly increased risk for EOC in the patients with As for the relation of this polymorphism to patients clinicopathologic parameters, no significant association was found either between the each genotype with phenotypes including stromal invasion, histologic type, surgical stage.
Our results may disclose the true pathophysiologic nature 
